Elacestrant, sold under the brand name Orserdu, is an anticancer medication. it is an estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. Reference standards of Elacestrant API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Elacestrant
Catalogue No.:PA 05 2150000
CAS :
Molecular Formula : C30H38N2O2
Molecular Weight : 458.65
(S)-Elacestrant Dihydrochloride
Catalogue No.:PA 05 2151000
Molecular Formula : C30H40Cl2N2O2
Molecular Weight : 531.56
(R)-6-(2-(Ethylamino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol
Catalogue No.:PA 05 2151001
Molecular Formula : C19H23NO2
Molecular Weight : 297.4
(R)-N-Ethyl-N-(4-((ethyl(2-(6-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-5-methoxyphenyl)amino)methyl)phenethyl)nitrous amide
Catalogue No.:PA 05 2151002
Molecular Formula : C30H37N3O3
Molecular Weight : 487.64
(S)-N-Ethyl-N-(4-((ethyl(2-(6-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-5-methoxyphenyl)amino)methyl)phenethyl)nitrous amide
Catalogue No.:PA 05 2151003
(R)-N-(4-(2-(Ethylamino)ethyl)benzyl)-N-(2-(6-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-5-methoxyphenyl)nitrous amide
Catalogue No.:PA 05 2151004
Molecular Formula : C28H33N3O3
Molecular Weight : 459.59
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
